Free Trial

Docusign (NASDAQ:DOCU) Reaches New 52-Week High - What's Next?

Docusign logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • DocuSign shares reached a new 52-week high of $75.31, supported by momentum in its AI-driven Intelligent Agreement Management platform and relative strength versus the broader market.
  • The company’s expanded integration with Salesforce, Agentforce and Slack could improve enterprise distribution, accelerate IAM adoption and generate additional subscription revenue.
  • Analysts remain cautious despite the rally: DocuSign has a consensus “Hold” rating and average price target of $67.33, while elevated valuation, cloud-migration costs and competition pose risks. Recent earnings exceeded expectations, with revenue up 9.4% year over year.
  • Five stocks to consider instead of Docusign.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) reached a new 52-week high during trading on Wednesday. The stock traded as high as $75.31 and last traded at $75.23, with a volume of 3,360,961 shares trading hands. The stock had previously closed at $72.31.

More Docusign News

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Expanded Salesforce integration is the primary catalyst. DocuSign’s Intelligent Agreement Management (IAM) platform will be embedded natively across Salesforce, Agentforce and Slack. The arrangement allows sales and revenue teams to manage agreements within their existing workflows and gives DocuSign access to Salesforce’s broad enterprise ecosystem. This could accelerate IAM adoption, improve customer engagement and support additional subscription revenue. DocuSign and Salesforce Launch Intelligent Agreement Management Natively Across Salesforce to Power Agentic Agreement Workflows
  • Positive Sentiment: The partnership extends a relationship that has lasted more than 20 years and positions DocuSign to participate in Salesforce’s AI and agentic-workflow expansion. Investors may view the native integration as a stronger distribution channel for DocuSign’s AI-enabled products than standalone selling. Docusign embeds agreement platform directly into Salesforce
  • Positive Sentiment: Zacks highlighted DOCU’s strong momentum, growing IAM adoption, AI-driven expansion and cash generation. The stock’s recent strength and trading near its 52-week high may be attracting momentum-focused investors. Here’s Why DocuSign Is a Strong Momentum Stock
  • Neutral Sentiment: Market coverage noted that DOCU advanced even as the broader market weakened, reinforcing its current relative strength. However, the shares’ elevated valuation means investors may require evidence that the Salesforce agreement translates into faster growth.
  • Negative Sentiment: Despite the constructive outlook, cloud-migration expenses and competition could pressure margins. Zacks therefore characterized DOCU as a stock to hold rather than an unqualified buy, leaving execution and profitability risks in focus. Here’s Why You Should Hold DOCU Stock in Your Portfolio Now

Analyst Ratings Changes

A number of equities analysts have recently commented on DOCU shares. Morgan Stanley boosted their price objective on Docusign from $69.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Friday, September 4th. UBS Group boosted their target price on shares of Docusign from $54.00 to $70.00 and gave the stock a "neutral" rating in a research note on Friday, September 4th. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a report on Friday, September 4th. Robert W. Baird upped their price objective on Docusign from $55.00 to $72.00 and gave the stock a "neutral" rating in a research report on Friday, September 4th. Finally, Royal Bank Of Canada boosted their target price on Docusign from $55.00 to $70.00 and gave the stock a "sector perform" rating in a research note on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Docusign has a consensus rating of "Hold" and an average target price of $67.33.

Read Our Latest Analysis on DOCU

Docusign Stock Performance

The stock has a market capitalization of $14.06 billion, a price-to-earnings ratio of 45.87, a PEG ratio of 2.63 and a beta of 0.86. The business has a 50-day moving average of $65.60 and a 200-day moving average of $54.15.

Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping the consensus estimate of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%. The company had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. During the same quarter in the previous year, the company posted $0.30 earnings per share. The firm's revenue was up 9.4% compared to the same quarter last year. On average, research analysts predict that Docusign Inc. will post 2.13 earnings per share for the current fiscal year.

Insider Transactions at Docusign

In other Docusign news, Director Mary Wilderotter sold 1,000 shares of the firm's stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $68.80, for a total transaction of $68,800.00. Following the transaction, the director directly owned 2,199 shares of the company's stock, valued at approximately $151,291.20. This trade represents a 31.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan C. Thygesen sold 26,250 shares of the stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $69.29, for a total transaction of $1,818,862.50. Following the sale, the chief executive officer owned 166,801 shares of the company's stock, valued at $11,557,641.29. This trade represents a 13.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 165,868 shares of company stock worth $11,121,890 over the last 90 days. Company insiders own 0.59% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Krilogy Financial LLC grew its position in Docusign by 4.0% in the 3rd quarter. Krilogy Financial LLC now owns 16,752 shares of the company's stock valued at $1,189,000 after buying an additional 640 shares during the last quarter. NorthCrest Asset Manangement LLC boosted its holdings in Docusign by 24.2% in the 3rd quarter. NorthCrest Asset Manangement LLC now owns 16,413 shares of the company's stock valued at $1,172,000 after purchasing an additional 3,200 shares in the last quarter. Riversedge Advisors LLC raised its stake in shares of Docusign by 4.5% during the 3rd quarter. Riversedge Advisors LLC now owns 5,182 shares of the company's stock worth $348,000 after buying an additional 225 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Docusign by 27.2% in the 3rd quarter. GAMMA Investing LLC now owns 5,033 shares of the company's stock valued at $338,000 after buying an additional 1,076 shares during the period. Finally, Green Alpha Advisors LLC lifted its holdings in shares of Docusign by 38.3% in the 3rd quarter. Green Alpha Advisors LLC now owns 13,417 shares of the company's stock valued at $901,000 after buying an additional 3,713 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Docusign Company Profile

(Get Free Report)

DocuSign, Inc NASDAQ: DOCU provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company's offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines